Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.
Hayakawa F, Mori N, Imai K, Yokoyama Y, Katsuoka Y, Saito T, Murayama T, Yamazaki E, Sato S, Atsuta Y, Ishikawa Y, Sakaida E, Hatta Y, Matsumura I, Miyazaki Y, Kiyoi H; Japan Adult Leukemia Study Group (JALSG).
Hayakawa F, et al. Among authors: mori n.
Cancer Sci. 2024 Nov 21. doi: 10.1111/cas.16405. Online ahead of print.
Cancer Sci. 2024.
PMID: 39572007
Free article.